What is the estimated creatinine clearance for dialysis patients with severely impaired renal function?

Creatinine Clearance in Dialysis Patients

For patients on dialysis with severely impaired renal function, the estimated creatinine clearance is generally considered to be less than 15 mL/min/1.73 m², which corresponds to end-stage renal disease (ESRD) or kidney failure requiring renal replacement therapy. 1

Understanding Creatinine Clearance in Dialysis Patients

• Patients on dialysis (hemodialysis or peritoneal dialysis) have severely impaired kidney function classified as Stage 5 Chronic Kidney Disease (CKD) or ESRD, with a glomerular filtration rate (GFR) of less than 15 mL/min/1.73 m² 1
• In clinical practice, patients requiring dialysis are considered to have minimal to no residual renal function, though some may maintain small amounts of residual function 2
• The Kidney Disease Outcomes Quality Initiative (KDOQI) guidelines classify kidney failure requiring renal replacement therapy as GFR <15 mL/min/1.73 m² 3

Medication Dosing Considerations

• For patients on hemodialysis, medication dosing should be adjusted according to their severely impaired renal function 2
• Many medications require significant dose reductions or extended dosing intervals for dialysis patients 2
• Examples of dosing adjustments for dialysis patients from guidelines include:
  • Lamivudine: 50 mg first dose, then 25 mg daily for hemodialysis patients 2
  • Tenofovir: 300 mg every 7 days for hemodialysis patients 2
  • Emtricitabine: 200 mg every 96 hours for hemodialysis patients 2

Residual Renal Function in Dialysis

• Some dialysis patients may maintain small amounts of residual renal function, which can be clinically significant 4
• For peritoneal dialysis patients, minimal acceptable creatinine clearance (combined peritoneal and residual renal) is approximately 54.4 L/1.73 m² weekly (equivalent to about 5.4 mL/min/1.73 m²) 4
• Residual renal function tends to decline over time on dialysis, particularly with hemodialysis 3

Clinical Implications

• Standard formulas for estimating creatinine clearance (like Cockcroft-Gault) are not reliable in dialysis patients due to their severely impaired renal function 5, 6
• Serum creatinine alone is an inadequate marker of renal function, especially in elderly patients who may have reduced muscle mass 6
• When evaluating medication dosing for dialysis patients, clinicians should:
  • Consider the drug's pharmacokinetics and dialyzability 2
  • Determine if the medication should be administered before or after dialysis 7
  • Recognize that most medications requiring renal adjustment will need the maximum adjustment for dialysis patients 2

Important Considerations

• Anticoagulants like NOACs (Non-vitamin K antagonist oral anticoagulants) are generally not recommended for patients with creatinine clearance <15 mL/min or on dialysis due to limited evidence and safety concerns 1
• For dialysis-dependent patients, drug dosing should be based on the understanding that their creatinine clearance is severely impaired (<15 mL/min) 2
• Some medications (like pomalidomide) may not require dose adjustment in severe renal impairment but should be administered after dialysis if dialyzable 7

Monitoring Recommendations

• Regular assessment of residual renal function may be beneficial, particularly in peritoneal dialysis patients 4
• For patients with acute kidney injury on temporary dialysis, monitoring for recovery of renal function is important to determine if dialysis can be discontinued 8
• A creatinine clearance >5 mL/min may predict the ability to terminate renal replacement therapy in patients with acute kidney injury 8